The effect of erbium and SVF laser treatment in the treatment of striae
Phase 1
Recruiting
- Conditions
- striae distensae.Atrophic disorder of skin, unspecifiedL90.6
- Registration Number
- IRCT20200127046282N14
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Diagnosis of striae distensae based on the diagnosis of a dermatologist
Patient satisfaction with the study
Age less than 50 years and more than 18 years
Exclusion Criteria
Use any treatment to eliminate striae in the last three months
Existence of skin lesions and diseases such as skin cancer
wart
Skin infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Striae size. Timepoint: Before and 3 months after the intervention. Method of measurement: biometry.
- Secondary Outcome Measures
Name Time Method Patient Satisfaction. Timepoint: Three months after treatment. Method of measurement: Questionnaire.;Pain. Timepoint: Injection time. Method of measurement: questionnaire.;Inflammation. Timepoint: 1-5 hours after injection. Method of measurement: questionnaire.